Clinical trial
Mesenchymal Stem Cells-Derived Extracellular Vesicles (MSC-EV) in Acute/Acute-on-Chronic Liver Failure After Liver Transplantationa:a Prospective, Randomized, Controlled Clinical Study
NCT06825572 is registered in ClinicalTrials.gov with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesenchymal Stem Cells-Derived Extracellular Vesicles (MSC-EV) in Acute/Acute-on-Chronic Liver Failure After Liver Transplantationa:a Prospective, Randomized, Controlled Clinical Study
- Lead sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- April 1, 2025
- Completion date
- September 30, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
extracellular vesicles, liver failure, mesenchymal stem cell